EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis

Detalles Bibliográficos
Autores principales: Prem, Shruti, Loach, David, Lipton, Jeffrey, Kumar, Rajat, Gupta, Vikas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2019
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942146/
https://www.ncbi.nlm.nih.gov/pubmed/31915655
http://dx.doi.org/10.5045/br.2019.54.4.282
_version_ 1783484655148728320
author Prem, Shruti
Loach, David
Lipton, Jeffrey
Kumar, Rajat
Gupta, Vikas
author_facet Prem, Shruti
Loach, David
Lipton, Jeffrey
Kumar, Rajat
Gupta, Vikas
author_sort Prem, Shruti
collection PubMed
description
format Online
Article
Text
id pubmed-6942146
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
record_format MEDLINE/PubMed
spelling pubmed-69421462020-01-08 EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis Prem, Shruti Loach, David Lipton, Jeffrey Kumar, Rajat Gupta, Vikas Blood Res Letter to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2019-12 2019-12-20 /pmc/articles/PMC6942146/ /pubmed/31915655 http://dx.doi.org/10.5045/br.2019.54.4.282 Text en © 2019 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Prem, Shruti
Loach, David
Lipton, Jeffrey
Kumar, Rajat
Gupta, Vikas
EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis
title EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis
title_full EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis
title_fullStr EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis
title_full_unstemmed EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis
title_short EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis
title_sort ebv reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942146/
https://www.ncbi.nlm.nih.gov/pubmed/31915655
http://dx.doi.org/10.5045/br.2019.54.4.282
work_keys_str_mv AT premshruti ebvreactivationmimickingalymphoproliferativedisorderassociatedwithruxolitinibtherapyformyelofibrosis
AT loachdavid ebvreactivationmimickingalymphoproliferativedisorderassociatedwithruxolitinibtherapyformyelofibrosis
AT liptonjeffrey ebvreactivationmimickingalymphoproliferativedisorderassociatedwithruxolitinibtherapyformyelofibrosis
AT kumarrajat ebvreactivationmimickingalymphoproliferativedisorderassociatedwithruxolitinibtherapyformyelofibrosis
AT guptavikas ebvreactivationmimickingalymphoproliferativedisorderassociatedwithruxolitinibtherapyformyelofibrosis

Ejemplares similares